A bill that has been introduced in the Indiana General Assembly is focusing on the use of ivermectin in the state for the treatment of COVID-19.Rep. Curt Nisly has authored House Bill 1372. The bill would allow a physician or advanced practice registered nurse to allow a pharmacist to dispense ivermectin.Additionally, the Medical Licensing Board of Indiana, the Indiana State Board of Nursing and the Indiana Board of Pharmacy may not deny, revoke, suspend or take disciplinary action against physicians, nurses or pharmacists who issue ivermectin to people.The bill also states that a pharmacist must provide each recipient of ivermectin with an information sheet that includes the importance of follow-up care and health care referral information."Nothing on the information sheet may discourage the recipient from using ivermectin for the treatment of COVID-19," the bill said.Last year, health officials in several states are warned residents not to take the anti-parasitic drug — in most cases, a formulation purchased at livestock supply centers — to treat or prevent COVID-19.While there are human uses for the drug, the Food and Drug Administration has not approved ivermectin to treat or prevent COVID-19 in humans."Currently available data do not show ivermectin is effective against COVID-19," the FDA wrote on its website.The bill had its first reading on Tuesday and was referred to the Committee on Public Health. Click here to read the full bill.
A bill that has been introduced in the Indiana General Assembly is focusing on the use of ivermectin in the state for the treatment of COVID-19.
Rep. Curt Nisly has authored House Bill 1372. The bill would allow a physician or advanced practice registered nurse to allow a pharmacist to dispense ivermectin.
Additionally, the Medical Licensing Board of Indiana, the Indiana State Board of Nursing and the Indiana Board of Pharmacy may not deny, revoke, suspend or take disciplinary action against physicians, nurses or pharmacists who issue ivermectin to people.
The bill also states that a pharmacist must provide each recipient of ivermectin with an information sheet that includes the importance of follow-up care and health care referral information.
"Nothing on the information sheet may discourage the recipient from using ivermectin for the treatment of COVID-19," the bill said.
Last year, health officials in several states are warned residents not to take the anti-parasitic drug — in most cases, a formulation purchased at livestock supply centers — to treat or prevent COVID-19.
While there are human uses for the drug, the Food and Drug Administration has not approved ivermectin to treat or prevent COVID-19 in humans.
"Currently available data do not show ivermectin is effective against COVID-19," the FDA wrote on its website.
The bill had its first reading on Tuesday and was referred to the Committee on Public Health. Click here to read the full bill.
Source link
